Skip to main content

Table 1 Baseline patient characteristics

From: Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-Trial)

Total patients 70
Male 53
Female 17
Patients with VL > 100.000 12
Patients with VL < 50 27
Mean age (years) 41,7 (range 20-72 years)
ART naïve 32
ART experienced 38
Mean viral load (copies/ml) 76375
ART naïve 161789
ART experienced 4448
Mean CD4 count (per μl) 377
ART naïve 255
ART experienced 480